Home › Companies › Medifast, Inc. › 2025-2026

Medifast, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Medifast, Inc.’s Form 8-K, filed 2026-05-26 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 10Reported items
  • 147Asset managers
  • 1,483Fund votes
  • 2026-05-19Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Medifast, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Medifast, Inc.

These tallies are Medifast, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-26 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Medifast, Inc. — official shareholder meeting results, meeting held 2026-05-19
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Daniel R. Chard 4,377,045261,81110,237 --1,840,102 Majority: yes
Elect Director: Elizabeth A. Geary 4,313,878323,55111,664 --1,840,102 Majority: yes
Elect Director: Parsa Kiai 4,378,697259,27911,117 --1,840,102 Majority: yes
Elect Director: Jeffrey Rose 4,398,976238,92911,188 --1,840,102 Majority: yes
Elect Director: Scott Schlackman 3,842,303795,60311,187 --1,840,102 Majority: yes
Elect Director: Andrea B. Thomas 4,260,999378,01210,082 --1,840,102 Majority: yes
Elect Director: Ming Xian 4,275,817356,33716,939 --1,840,102 Majority: yes
Accordingly, each of the individuals listed above was elected to the Company's Board of Directors, each to hold office until the Company's next annual meeting of stockholders and until his or her successor is duly elected and qualified, or 6,411,17553,44424,576 ---- Majority: yes
(iii) The stockholders voted on a proposal to approve, on an advisory basis, the compensation of the Company's named executive officers as set forth in the proxy statement for the Annual Meeting. 3,996,046637,17315,874 --1,840,102 Majority: yes
(iv) The stockholders voted on a proposal to approve the Amended 2012 Plan. 3,195,0781,442,99711,018 --1,840,102 Majority: yes

Source: Medifast, Inc., Form 8-K, filed with the SEC on 2026-05-26 — read the filing on EDGAR.

How asset managers voted at the Medifast, Inc. 2025-2026 meeting

Each item below shows how the 147 asset managers that disclosed a Medifast, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Medifast, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approve, on an advisory basis, the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%14%
FOR: 3,996,046AGAINST: 637,173

Medifast, Inc.’s own tally for this item (“(iii) The stockholders voted on a proposal to approve, on an advisory basis, the compensation of the Company's named executive officers as set forth in the proxy statement for the Annual Meeting.”): 3,996,046 for, 637,173 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 11,119,115 outstanding shares: 36% for, 6% against (42% of the company cast a for/against vote).

The 146 asset managers below cast 87% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 87%13%
FOR: 87.5%AGAINST: 12.5%ABSTAIN: 0.0%
Largest asset managers voting on “Approve, on an advisory basis, the compensation of the Company's named executive officers.” at Medifast, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab1,259,9390 00For
Steamboat Capital Partners, LLC595,0230 00For
Vanguard550,257579 00For
BlackRock451,3827,891 00For
Renaissance412,2560 00For
American Century0226,106 00Against
Man Group plc189,3370 00For
Federated Hermes133,2340 00For
Peapod Lane Capital LLC0123,771 00Against
DE Shaw109,2320 00For
Goldman Sachs93,0690 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC90,4870 00For
State Street82,41037 00For
Two Sigma77,8290 00For
T. Rowe Price72,1700 00For
EA Series Trust22,67248,850 00Against
Victory Capital66,5360 00For
Northern Trust63,8660 00For
Dimensional054,183 00Against
BRIDGEWAY CAPITAL MANAGEMENT, LLC046,046 00Against
BRIDGEWAY FUNDS INC044,146 00Against
PIMCO40,8250 00For
AllianceBernstein027,320 00Against
Nuveen026,563 00Against
AQR24,9170 00For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

2. Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Daniel R. Chard

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 4,377,045AGAINST: 261,811

Medifast, Inc.’s own tally for this item (“Elect Director: Daniel R. Chard”): 4,377,045 for, 261,811 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 11,119,115 outstanding shares: 39% for, 2% against (42% of the company cast a for/against vote).

The 47 asset managers below cast 99.9% of the shares they voted on this item FOR (2,035,836 for, 1,285 against).

FOR 99.9%
FOR: 2,035,836 (99.9%)AGAINST: 1,285 (0.1%)
Largest asset managers voting on “Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Daniel R. Chard” at Medifast, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab629,9530 00For
Vanguard482,4421,229 00For
BlackRock326,9430 00For
American Century112,4960 00For
EA Series Trust71,5220 00For
Federated Hermes65,8590 00For
BRIDGEWAY FUNDS INC44,1460 00For
Dimensional42,5750 00For
PIMCO40,8250 00For
Victory Capital33,2680 00For
TIAA23,3040 00For
Equitable21,0910 00For
Goldman Sachs19,9480 00For
Fidelity19,0680 00For
QUANTITATIVE MASTER SERIES LLC17,7870 00For
JPMorgan14,0540 00For
Invesco10,3110 00For
Venerable Variable Insurance Trust8,9860 00For
Lincoln Financial7,4290 00For
Northern Trust6,0660 00For
Global X5,0700 00For
Pacific Life4,8210 00For
Bridge Builder Trust4,7100 00For
AIG/SunAmerica3,2600 00For
GPS Funds I2,9450 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

3. Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Elizabeth A. Geary

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 4,313,878AGAINST: 323,551

Medifast, Inc.’s own tally for this item (“Elect Director: Elizabeth A. Geary”): 4,313,878 for, 323,551 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 11,119,115 outstanding shares: 39% for, 3% against (42% of the company cast a for/against vote).

The 47 asset managers below cast 97% of the shares they voted on this item FOR (1,970,193 for, 66,926 against).

FOR 97%
FOR: 1,970,193 (96.7%)AGAINST: 66,926 (3.3%)
Largest asset managers voting on “Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Elizabeth A. Gea” at Medifast, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab629,9530 00For
Vanguard483,6690 00For
BlackRock326,9430 00For
American Century112,4960 00For
EA Series Trust71,5220 00For
Federated Hermes065,859 00Against
BRIDGEWAY FUNDS INC44,1460 00For
Dimensional42,5750 00For
PIMCO40,8250 00For
Victory Capital33,2680 00For
TIAA23,3040 00For
Equitable21,0910 00For
Goldman Sachs19,9480 00For
Fidelity19,0680 00For
QUANTITATIVE MASTER SERIES LLC17,7870 00For
JPMorgan14,0540 00For
Invesco10,3110 00For
Venerable Variable Insurance Trust8,9860 00For
Lincoln Financial7,4290 00For
Northern Trust6,0660 00For
Global X5,0700 00For
Pacific Life4,8210 00For
Bridge Builder Trust4,7100 00For
AIG/SunAmerica3,2600 00For
GPS Funds I2,9450 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

4. Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Parsa Kiai

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 4,378,697AGAINST: 259,279

Medifast, Inc.’s own tally for this item (“Elect Director: Parsa Kiai”): 4,378,697 for, 259,279 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 11,119,115 outstanding shares: 39% for, 2% against (42% of the company cast a for/against vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (2,037,120 for, 0 against).

FOR 100%
FOR: 2,037,120 (100.0%)
Largest asset managers voting on “Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Parsa Kiai” at Medifast, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab629,9530 00For
Vanguard483,6700 00For
BlackRock326,9430 00For
American Century112,4960 00For
EA Series Trust71,5220 00For
Federated Hermes65,8590 00For
BRIDGEWAY FUNDS INC44,1460 00For
Dimensional42,5750 00For
PIMCO40,8250 00For
Victory Capital33,2680 00For
TIAA23,3040 00For
Equitable21,0910 00For
Goldman Sachs19,9480 00For
Fidelity19,0680 00For
QUANTITATIVE MASTER SERIES LLC17,7870 00For
JPMorgan14,0540 00For
Invesco10,3110 00For
Venerable Variable Insurance Trust8,9860 00For
Lincoln Financial7,4290 00For
Northern Trust6,0660 00For
Global X5,0700 00For
Pacific Life4,8210 00For
Bridge Builder Trust4,7100 00For
AIG/SunAmerica3,2600 00For
GPS Funds I2,9450 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

5. Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Jeffrey Rose

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 4,398,976AGAINST: 238,929

Medifast, Inc.’s own tally for this item (“Elect Director: Jeffrey Rose”): 4,398,976 for, 238,929 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 11,119,115 outstanding shares: 40% for, 2% against (42% of the company cast a for/against vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (2,037,120 for, 0 against).

FOR 100%
FOR: 2,037,120 (100.0%)
Largest asset managers voting on “Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Jeffrey Rose” at Medifast, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab629,9530 00For
Vanguard483,6700 00For
BlackRock326,9430 00For
American Century112,4960 00For
EA Series Trust71,5220 00For
Federated Hermes65,8590 00For
BRIDGEWAY FUNDS INC44,1460 00For
Dimensional42,5750 00For
PIMCO40,8250 00For
Victory Capital33,2680 00For
TIAA23,3040 00For
Equitable21,0910 00For
Goldman Sachs19,9480 00For
Fidelity19,0680 00For
QUANTITATIVE MASTER SERIES LLC17,7870 00For
JPMorgan14,0540 00For
Invesco10,3110 00For
Venerable Variable Insurance Trust8,9860 00For
Lincoln Financial7,4290 00For
Northern Trust6,0660 00For
Global X5,0700 00For
Pacific Life4,8210 00For
Bridge Builder Trust4,7100 00For
AIG/SunAmerica3,2600 00For
GPS Funds I2,9450 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

6. Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Scott Schlackman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%
FOR: 3,842,303AGAINST: 795,603

Medifast, Inc.’s own tally for this item (“Elect Director: Scott Schlackman”): 3,842,303 for, 795,603 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 11,119,115 outstanding shares: 35% for, 7% against (42% of the company cast a for/against vote).

The 47 asset managers below cast 79% of the shares they voted on this item FOR (1,604,324 for, 432,797 against).

FOR 79%AGAINST 21%
FOR: 1,604,324 (78.8%)AGAINST: 432,797 (21.2%)
Largest asset managers voting on “Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Scott Schlackman” at Medifast, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab629,9530 00For
Vanguard481,8661,805 00For
BlackRock0326,943 00Against
American Century112,4960 00For
EA Series Trust22,67248,850 00Against
Federated Hermes65,8590 00For
BRIDGEWAY FUNDS INC44,1460 00For
Dimensional42,5750 00For
PIMCO40,8250 00For
Victory Capital33,2680 00For
TIAA023,304 00Against
Equitable17,5003,591 00For
Goldman Sachs19,9480 00For
Fidelity19,0680 00For
QUANTITATIVE MASTER SERIES LLC017,787 00Against
JPMorgan14,0540 00For
Invesco10,3110 00For
Venerable Variable Insurance Trust8,9860 00For
Lincoln Financial7,4290 00For
Northern Trust6,0660 00For
Global X5,0700 00For
Pacific Life04,821 00Against
Bridge Builder Trust04,710 00Against
AIG/SunAmerica3,2600 00For
GPS Funds I2,9450 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

7. Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Andrea B. Thomas

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 4,260,999AGAINST: 378,012

Medifast, Inc.’s own tally for this item (“Elect Director: Andrea B. Thomas”): 4,260,999 for, 378,012 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 11,119,115 outstanding shares: 38% for, 3% against (42% of the company cast a for/against vote).

The 47 asset managers below cast 95% of the shares they voted on this item FOR (1,935,293 for, 101,828 against).

FOR 95%
FOR: 1,935,293 (95.0%)AGAINST: 101,828 (5.0%)
Largest asset managers voting on “Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Andrea B. Thomas” at Medifast, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab629,9530 00For
Vanguard482,4401,231 00For
BlackRock326,9430 00For
American Century112,4960 00For
EA Series Trust71,5220 00For
Federated Hermes065,859 00Against
BRIDGEWAY FUNDS INC44,1460 00For
Dimensional42,5750 00For
PIMCO40,8250 00For
Victory Capital33,2680 00For
TIAA023,304 00Against
Equitable21,0910 00For
Goldman Sachs19,9480 00For
Fidelity19,0680 00For
QUANTITATIVE MASTER SERIES LLC17,7870 00For
JPMorgan14,0540 00For
Invesco010,311 00Against
Venerable Variable Insurance Trust8,9860 00For
Lincoln Financial7,4290 00For
Northern Trust6,0660 00For
Global X5,0700 00For
Pacific Life4,8210 00For
Bridge Builder Trust4,7100 00For
AIG/SunAmerica3,2600 00For
GPS Funds I2,9450 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

8. Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Ming Xian

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 4,275,817AGAINST: 356,337

Medifast, Inc.’s own tally for this item (“Elect Director: Ming Xian”): 4,275,817 for, 356,337 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 11,119,115 outstanding shares: 38% for, 3% against (42% of the company cast a for/against vote).

The 47 asset managers below cast 97% of the shares they voted on this item FOR (1,968,908 for, 68,213 against).

FOR 97%
FOR: 1,968,908 (96.7%)AGAINST: 68,213 (3.3%)
Largest asset managers voting on “Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Ming Xian” at Medifast, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab629,9530 00For
Vanguard482,4401,231 00For
BlackRock326,9430 00For
American Century112,4960 00For
EA Series Trust71,5220 00For
Federated Hermes065,859 00Against
BRIDGEWAY FUNDS INC44,1460 00For
Dimensional42,5750 00For
PIMCO40,8250 00For
Victory Capital33,2680 00For
TIAA23,3040 00For
Equitable21,0910 00For
Goldman Sachs19,9480 00For
Fidelity19,0680 00For
QUANTITATIVE MASTER SERIES LLC17,7870 00For
JPMorgan14,0540 00For
Invesco10,3110 00For
Venerable Variable Insurance Trust8,9860 00For
Lincoln Financial7,4290 00For
Northern Trust6,0660 00For
Global X5,0700 00For
Pacific Life4,8210 00For
Bridge Builder Trust4,7100 00For
AIG/SunAmerica3,2600 00For
GPS Funds I2,9450 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

9. Ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026.

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 47 asset managers below cast 100% of the shares they voted on this item FOR (2,037,120 for, 0 against).

FOR: 2,037,120 (100.0%)
Largest asset managers voting on “Ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for t” at Medifast, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab629,9530 00For
Vanguard483,6700 00For
BlackRock326,9430 00For
American Century112,4960 00For
EA Series Trust71,5220 00For
Federated Hermes65,8590 00For
BRIDGEWAY FUNDS INC44,1460 00For
Dimensional42,5750 00For
PIMCO40,8250 00For
Victory Capital33,2680 00For
TIAA23,3040 00For
Equitable21,0910 00For
Goldman Sachs19,9480 00For
Fidelity19,0680 00For
QUANTITATIVE MASTER SERIES LLC17,7870 00For
JPMorgan14,0540 00For
Invesco10,3110 00For
Venerable Variable Insurance Trust8,9860 00For
Lincoln Financial7,4290 00For
Northern Trust6,0660 00For
Global X5,0700 00For
Pacific Life4,8210 00For
Bridge Builder Trust4,7100 00For
AIG/SunAmerica3,2600 00For
GPS Funds I2,9450 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

10. Approve the Amended and Restated 2012 Share Incentive Plan.

COMPENSATIONMajority of the votes cast: yes

69% Majority: yes · of votes cast

FOR 69%AGAINST 31%
FOR: 3,195,078AGAINST: 1,442,997

Medifast, Inc.’s own tally for this item (“(iv) The stockholders voted on a proposal to approve the Amended 2012 Plan.”): 3,195,078 for, 1,442,997 against, per its Form 8-K filed 2026-05-26 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 11,119,115 outstanding shares: 29% for, 13% against (42% of the company cast a for/against vote).

The 47 asset managers below cast 58% of the shares they voted on this item FOR (1,187,273 for, 849,848 against).

FOR 58%AGAINST 42%
FOR: 1,187,273 (58.3%)AGAINST: 849,848 (41.7%)
Largest asset managers voting on “Approve the Amended and Restated 2012 Share Incentive Plan.” at Medifast, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab0629,953 00Against
Vanguard481,8591,812 00For
BlackRock326,9430 00For
American Century0112,496 00Against
EA Series Trust22,67248,850 00Against
Federated Hermes65,8590 00For
BRIDGEWAY FUNDS INC44,1460 00For
Dimensional42,5750 00For
PIMCO40,8250 00For
Victory Capital33,2680 00For
TIAA023,304 00Against
Equitable3,59117,500 00Against
Goldman Sachs19,9480 00For
Fidelity19,0680 00For
QUANTITATIVE MASTER SERIES LLC17,7870 00For
JPMorgan14,0540 00For
Invesco10,3110 00For
Venerable Variable Insurance Trust8,093893 00For
Lincoln Financial7,4290 00For
Northern Trust06,066 00Against
Global X05,070 00Against
Pacific Life4,8210 00For
Bridge Builder Trust4,7100 00For
AIG/SunAmerica3,2600 00For
GPS Funds I2,9450 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

Largest Medifast, Inc. shareholders voting in 2025-2026

Ranked by the number of Medifast, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 11,119,115 shares outstanding at the time of that meeting.

Top Medifast, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Charles Schwab 11.33%
2Steamboat Capital Partners, LLC 5.35%
3Vanguard 4.95%
4BlackRock 4.13%
5Renaissance 3.71%
6American Century 2.03%
7Man Group plc 1.70%
8Federated Hermes 1.20%
9Peapod Lane Capital LLC 1.11%
10DE Shaw 0.98%

Reported Medifast, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Medifast, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 8.49% 13F
Renaissance Technologies 6.96% 13F
Citadel Advisors 6.69% 13F
Vanguard Group 6.40% 13F
Charles Schwab 5.68% 13F
Susquehanna Portfolio Strategies, LLC 5.28% 13G
Dimensional Fund Advisors 3.25% 13F
Two Sigma 3.04% 13F
Morgan Stanley 3.01% 13F
Kenneth Griffin 2.61% 13G

Percentages above are of 11,119,115 shares outstanding, as reported by Medifast, Inc. on its Form 10-Q dated 2026-04-27 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Medifast, Inc.’s 10-Q dated 2026-04-27. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Medifast, Inc.'s shareholder meeting held 2026-05-19, in the 2025-2026 proxy season, 147 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,483 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approve, on an advisory basis, the compensation of the Company's named executive officers. — FOR was 86% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Medifast, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-26.

Medifast, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).